Characterization of the GBoV1 capsid and its antibody interactions

Jennifer Yu, Mario Mietzsch, Amriti Singh, Alberto Jimenez Ybargollin, Dirk Grimm, Amit Kapoor, Indrė Kučinskaitė-Kodzė, Aurelija Žvirblienė, Maria Söderlund-Venermo, Robert McKenna, Mavis Agbandje-McKenna

Research output: Contribution to journalArticleScientificpeer-review

Abstract

Human bocavirus 1 (HBoV1) has gained attention as a gene delivery vector with its ability to infect polarized human airway epithelia and 5.5 kb genome packaging capacity. Gorilla bocavirus 1 (GBoV1) VP3 shares 86% amino acid sequence identity with HBoV1 but has better transduction efficiency in several human cell types. Here, we report the capsid structure of GBoV1 determined to 2.76 angstrom resolution using cryo-electron microscopy (cryo-EM) and its interaction with mouse monoclonal antibodies (mAbs) and human sera. GBoV1 shares capsid surface morphologies with other parvoviruses, with a channel at the 5-fold symmetry axis, protrusions surrounding the 3-fold axis and a depression at the 2-fold axis. A 2/5-fold wall separates the 2-fold and 5-fold axes. Compared to HBoV1, differences are localized to the 3-fold protrusions. Consistently, native dot immunoblots and cryo-EM showed cross-reactivity and binding, respectively, by a 5-fold targeted HBoV1 mAb, 15C6. Surprisingly, recognition was observed for one out of three 3-fold targeted mAbs, 12C1, indicating some structural similarity at this region. In addition, GBoV1, tested against 40 human sera, showed the similar rates of seropositivity as HBoV1. Immunogenic reactivity against parvoviral vectors is a significant barrier to efficient gene delivery. This study is a step towards optimizing bocaparvovirus vectors with antibody escape properties.

Original languageEnglish
Article number330
JournalViruses (Basel)
Volume13
Issue number2
Number of pages17
ISSN1999-4915
DOIs
Publication statusPublished - Feb 2021
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 11832 Microbiology and virology
  • bocavirus
  • capsid
  • parvovirus
  • cryo-EM
  • gene therapy
  • antigenicity
  • bocavirus
  • capsid
  • parvovirus
  • cryo-EM
  • gene therapy
  • antigenicity

Cite this